EGFR-IN-57 structure
|
Common Name | EGFR-IN-57 | ||
---|---|---|---|---|
CAS Number | 2492382-37-1 | Molecular Weight | 385.44 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H15N3O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of EGFR-IN-57EGFR-IN-57 (Compound 25a) is a potent, orally active EGFR-TK inhibitor with an IC50 of 0.054 µM. EGFR-IN-57 also inhibits VEGFR-2, CK2α, topoisomerase IIβ and tubulin polymerization with IC50 values of 0.087, 0.171, 0.13 and 3.61 µM, respectively. EGFR-IN-57 induces cell cycle arrest at G2/M and pre-G1 phases. EGFR-IN-57 induces cancer cell apoptosis[1]. |
Name | EGFR-IN-57 |
---|
Description | EGFR-IN-57 (Compound 25a) is a potent, orally active EGFR-TK inhibitor with an IC50 of 0.054 µM. EGFR-IN-57 also inhibits VEGFR-2, CK2α, topoisomerase IIβ and tubulin polymerization with IC50 values of 0.087, 0.171, 0.13 and 3.61 µM, respectively. EGFR-IN-57 induces cell cycle arrest at G2/M and pre-G1 phases. EGFR-IN-57 induces cancer cell apoptosis[1]. |
---|---|
Related Catalog | |
Target |
EGFR:0.054 μM (IC50) VEGFR-2:0.087 μM (IC50) CK2α:0.171 μM (IC50) topoisomerase II beta:0.13 μM (IC50) tubulin polymerization:3.16 μM (IC50) |
References |
Molecular Formula | C22H15N3O2S |
---|---|
Molecular Weight | 385.44 |